The authors discusses the study conducted by K. Saravu and colleagues which examines the determinants of ventilator-associated pneumonia (VAP) and its impact on prognosis. They note that the use of steroids, reintubation, and bacteremia can contribute to the occurrence of VAP. They add that Acinetobacter is the emerging pathogen for VAP drug-resistant.